Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.44M Sell
8,786
-140
-2% -$39.6K 0.07% 134
2026
Q1
$2.35M Buy
8,926
+3,250
+57% +$899K 0.07% 131
2025
Q4
$1.57M Buy
5,676
+40
+0.7% +$11.2K 0.04% 159
2025
Q3
$1.62M Sell
5,636
-41
-0.7% -$12.1K 0.05% 137
2025
Q2
$1.88M Hold
5,677
0.06% 136
2025
Q1
$1.85M Buy
5,677
+2,014
+55% +$607K 0.08% 122
2024
Q4
$1.01M Hold
3,663
0.01% 169
2024
Q3
$1.27M Hold
3,663
0.05% 141
2024
Q2
$1.22M Hold
3,663
0.06% 128
2024
Q1
$1.33M Buy
+3,663
New +$1.21M 0.06% 136

Other funds holding CI

BNP Paribas's CI Position: Q2 2026 in Review

BNP Paribas reduced its Cigna (CI) stake by 1.6% in Q2 2026, selling an estimated $39.6K and leaving 8,786 shares worth $2.44M. The position accounts for 0.07% of the portfolio, ranked #134.

BNP Paribas first reported a position in CI in Q1 2024 and has held it in 10 quarters since. 1,699 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • BNP Paribas held 8,786 shares of Cigna worth $2.44M as of Q2 2026.
  • BNP Paribas sold 140 Cigna shares in Q2 2026, an estimated $39.6K.
  • Cigna made up 0.07% of BNP Paribas's portfolio in Q2 2026, its #134 holding.
  • BNP Paribas first reported a position in Cigna in Q1 2024 and has held it in 10 quarters since.
  • 1,699 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.